Overall rank by patents
#31,352
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 6 technology areas, active 2016–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: Y04S (SYSTEMS INTEGRATING TECHNOLOGIES RELATED TO POWER NETWORK OPERATION, COMMUNICATION OR INFORMATION TECHNOLOGIES FOR IMPROVING THE ELECTRICAL POWER GENERATION, TRANSMISSION, DISTRIBUTION, MANAGEMENT OR ).
The verdict
D&r holds 8 US patents across 6 technology areas, rank #31,352 of 50,000 tracked assignees.
D&R Tech Llc has been granted 8 US utility patents between 2016 and 2024, placing D&R Tech Llc at rank #31,352 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.3 claims per patent with primary concentration in Y04S (SYSTEMS INTEGRATING TECHNOLOGIES RELATED TO POWER NETWORK OPERATION, COMMUNICATION OR INFORMATION TECHNOLOGIES FOR IMPROVING THE ELECTRICAL POWER GENERATION, TRANSMISSION, DISTRIBUTION, MANAGEMENT OR ). As a US Corporation, D&R Tech Llc is one of the more focused assignees in the PatentsView dataset. By volume, D&r sits between Cytlimic Inc. (8 patents, rank #31,348) and Daiken Medical Co., Ltd. (8 patents, rank #31,356) - the closest US assignees by grant volume. The composite Innovation Score of 48.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 4 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. D&R Tech Llc's 20.3 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark D&R Tech Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Cytlimic Inc.
8 patents
CytoVale Inc.
8 patents
CytoVeris, Inc.
8 patents
D Three Enterprises, LLC
8 patents
D. LA PORTE SÖHNE GMBH
8 patents
D3D Technologies, Inc.
8 patents
DAEYOUNG CHAEVI CO., LTD.
8 patents
DAIKEN MEDICAL CO., LTD.
8 patents
D&R Tech LLC
8 patents
What this shows D&R holds 8 patents at rank #31,352, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,352 in granted patent volume.
Other assignees with the most granted patents in D&R's primary technology class.
D&r's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 12.5% |
| 2017 | 1 | 12.5% |
| 2018 | 2 | 25.0% |
| 2020 | 1 | 12.5% |
| 2022 | 1 | 12.5% |
| 2023 | 1 | 12.5% |
| 2024 | 1 | 12.5% |
Top 6 of 6 technology areas
Overall rank by patents
#31,352
Across all tracked assignees
48.4 out of 100
How to use this portfolio
D&r's 8 grants land it in the top 17% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.